Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria

Finlay, Andrew Y. ORCID: https://orcid.org/0000-0003-2143-1646, Kaplan, A.P., Beck, L.A., Antonova, E.N., Balp, M.-M., Zazzali, J., Khalil, S. and Maurer, M. 2017. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology 31 (10) , pp. 1715-1721. 10.1111/jdv.14384

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution No Derivatives. Download (328kB) | Preview

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Blackwell Publishing
ISSN:	0926-9959
Date of First Compliant Deposit:	9 August 2017
Date of Acceptance:	9 May 2017
Last Modified:	17 Nov 2024 06:45
URI:	https://orca.cardiff.ac.uk/id/eprint/103461

Citation Data

Cited 42 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item